期刊文献+

白血病K562/ADM细胞耐药性与白血病干细胞及耐药蛋白表达的关系 被引量:9

The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562/ADM cells
原文传递
导出
摘要 目的观察白血病药物敏感和耐受细胞中自血病干细胞(LSC)、耐药蛋白表达和耐药性的关系。方法以白血病多药耐药株K562/ADM细胞及其亲本K562细胞为模型,MTT比色法测定细胞的药物耐受性;流式细胞术检测细胞免疫标志、P-糖蛋白(P—gP)和乳腺癌耐药蛋白(BCRP)的表达;甲基纤维素集落形成法检测细胞的自我更新和增殖潜能。结果K562/ADM细胞对阿霉素、柔红霉素和鬼臼乙叉苷高度耐受。K562/ADM细胞中CD34^+、CD123^+和CD34^+CD38^-细胞含量均显著高于K562细胞,LSC细胞相对含量是K562细胞的4.12倍;共表达P-gP和BCRP的K562/ADM细胞比K562细胞高11.25倍,其中CD34^+CD38^-CD123^+BCRP^+和CD34^+CD38^-P—gP^+BCRP^+细胞数量分别为K562细胞的3.66倍和11.37倍。K562/ADM细胞集落形成率是K562细胞的4.17倍,与LSC含量相当。结论白血病K562/ADM耐药细胞中存在的高表达耐药蛋白的耐药性LSC是其多药物耐受性的根源。 Objective To investigate the drug resistance, proportion of leukemia stem cells (LSC) and expression of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) in drug-sensitive and multidrug-resistant leukemia cell population. Methods The multidrug-resistant leukemia K562/ADM cell and its parental K562 cell were used as the model cells. The drug sensitivity was tested with a MTT assay. Flow cytometry was employed to detect the immunophenotype of stem cells and the expression of P-gp and BCRP. The self-renewal and proliferating potential were examined with methylcellulose colony-forming unit assay. Results K562/ADM ceils were highly resistant to adriamyein, daunorubincin and etoposide. The amount of CD34^+ , CD123^+ and CD34^+ CD38^- cells in K562/ADM cells was much higher than that in K562 cells, and the proportion of CD34^+ CD38^-CD123^+ cells(LSC)in K562/ADM cells was (5.23±0. 21 )% versus ( 1.27±0. 17)% in K562 cells, which was 4. 12-fold higher than that in K562 cells. Both P-gp and BCRP were overexpressed in K562/ADM cells relative to K562 cells, and the K562/ADM cells coexpressing P-gp and BCRP were 11.25-fold higher over K562 ceils. The proportion of CD34^+ CD38^- CD123^+ BCRP^+ and CD34^+ CD38^- P-gp^+ BCRP^+ cells in K562/ADM cells were (4. 13±0. 40) % and (5.80±1.19)% respectively, which were 3.66- and 11.37-fold higher than the same cells in K562 cells [(1.13±0. 15)% and(0. 51±0. 01)%]. Furthermore, drug-resistant K562/ADM cells displayed 4. 17- time greater colony-forming ability over the parent K562 cells, corresponding to the proportion of LSCs in K562/ADM cells. Conclusions The ABC transporters-overexpressing LSC population exists in drug- resistant leukemic K562/ADM cells relative to drug-sensitive K562 cells, and the drug-resistant LSCs may be the source of chemotherapeutic resistance of leukemia.
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第25期1741-1744,共4页 National Medical Journal of China
基金 中草药物质基础与资源利用教育部重点实验室(北京协和医学院)开放课题资助项目(0801) 甘肃省新药临床前研究重点实验室(兰州大学)开放课题资助项目(GSKFKT-0802)
关键词 抗药性 多药 P-糖蛋白 乳腺癌耐药蛋白 集落形成 白血病干细胞 Drug resistance, multiple P-glycoprotein BCRP protein, human Colony-forming units assay Leukemia stern cell
  • 相关文献

参考文献10

  • 1杨纯正.白血病干细胞的靶向治疗[J].中华医学杂志,2007,87(20):1372-1374. 被引量:1
  • 2Ravandi V,Estrov Z.Eradication of leukemia stem cells as a new goal of therapy in leukemia.Clin Cancer Res,2006,12:340-344. 被引量:1
  • 3de Figueiredo-Pontes LL,Pintao MC,Oliveira LC,et al.Determination of P-glycoprotein,MDR-related protein 1,breast cancer resistance protein,and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.Cytometry B Clin Cytom,2008,74:163-168. 被引量:1
  • 4Dean M,Fojo T,Bates S.Tumour stem cells and drag resistance.Nat Rev Cancer,2005,5:275-284. 被引量:1
  • 5Eyler CE,Rich JN.Survival of the fittest:cancer stem cells in therapeutic resistance and angiogenesis.J Clin Oncol,2008,26:2839-2845. 被引量:1
  • 6魏虎来,姚小健,李宇宁,王蓓,赵怀顺,白德成,彭晓,马兰芳.三氧化二砷抑制K562/ADM细胞P-糖蛋白表达并提高化疗药物的敏感性[J].中华血液学杂志,2003,24(1):28-31. 被引量:21
  • 7Puissant A,Grosso S,Jacquel A,et al.Imatinib mesylateresistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol.FASEB J,2008,22:1894-1904. 被引量:1
  • 8de Jonge-Peeters SD,Kuipers F,de Vries EG,et al.ABC transporter expression in hematopoietie stem cells and the role in AML drug resistance.Crit Rev Oncol Hernatol,2007,62:214-226. 被引量:1
  • 9Raaijmakers MH.ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.Leukemia,2007,21:2094-2102. 被引量:1
  • 10Ho MM,D Hngge E,Ling V.MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.Exp Hematol,2008,36:433-442. 被引量:1

二级参考文献21

  • 1Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 1994,367:645-648. 被引量:1
  • 2Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 1997,3:730-737. 被引量:1
  • 3Pileri SA,Zinzani PA, Went P, et al. 2004 Characterization of clonogenic multiple myeloma cells. Ann Oncol,2004,15 : 12-18. 被引量:1
  • 4Marx J. A Boost for Tumor Starvation. Science,2003,301 : 452. 被引量:1
  • 5HuffCA,Mutsui WH, Smith BD, et al. Strategies to eliminate cancer stem cell : Clinical implications. Eur J Cancer,2006,42: 1293-1297. 被引量:1
  • 6Cortes J,O'Brien S, Kantarijian H, et al. Discontinunation of imatinib therapy after achieving a molecular response. Blood, 2004,104:2204-2205. 被引量:1
  • 7Mauro MJ, Druker BJ, Kuyl J, et al. Increasing levels of detectable leukemia in imatinib treated CML patients with previously undetectable or very low levels of BCR-ABL. Proc ASCO,2003,22 : 569. 被引量:1
  • 8Angstreich GR, Matsui W, Huff CA, et al. Effects of imatinib and interferon on primitive chronic myeloid leukemia progenitors. Brit J Haematol,2005,130 : 373-381. 被引量:1
  • 9JiangG,Yang F, Li M, et al. Imatinib provides only limited selectivity for CML cells and treatment might be complicated by silent BCR-ABL genes. Cancer Biol Ther,2003,2: 103-108. 被引量:1
  • 10Matsui WH, Huff CA, Wang Q, et al. Multiple myeloma stem cells and plasma cells display distinct drug sensitivities. Blood, 2004,104: 679a. 被引量:1

共引文献20

同被引文献63

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部